PT-141 Side Effects: Nausea, Flushing, Blood Pressure and What to Report

These rates come from RECONNECT, two identical 24-week randomised, double-blind, placebo-controlled trials in 1,267 premenopausal women with acquired, generalised hypoactive sexual desire disorder, published in Obstetrics & Gynecology in 2019, which tested a 1.75 mg dose of bremelanotide used as needed. The medications this page covers:

Prices are all-in: medication, physician review, refill management and shipping, with no membership fee. Compounded PT-141 is the same molecule as the active ingredient of an FDA-approved drug, which is why the trial and label data apply to it. The compounded vial itself has not been trialled, and compounded medications are not FDA approved.

Because PT-141 is used on the occasion, side effects follow the clock of each dose, not a weekly schedule.

The approved label reports a half-life of about 2.7 hours. Nothing in the trial programme describes dependence, withdrawal or rebound; the effects are per dose, so stopping means they are not there. The one effect that may not fully reverse is focal hyperpigmentation in the minority who develop it.

Blood pressure and heart rate

Each dose causes a transient rise in blood pressure: about 6 mmHg systolic and 3 mmHg diastolic at most in the trials, peaking two to four hours after the dose and usually back to baseline within twelve. Heart rate falls by up to 5 beats a minute over the same period. That is why the approved label contraindicates use in uncontrolled hypertension or known cardiovascular disease, and why no more than one dose is taken in 24 hours. A compounded vial does not change that pharmacology.

Skin, gum and breast darkening

Bremelanotide's strongest receptor affinity is for MC1R, the receptor on melanocytes. It keeps some of the pigmentation activity of Melanotan II, the molecule it descends from. Focal hyperpigmentation, involving the face, gums and breasts, was reported by 1% of women dosing up to eight times a month, but by 38% of people given it daily for eight days in a separate study, and it did not always resolve after stopping. That difference is the reason the dose is capped by month. Pepti's typical PT-141 directions cap use at four doses a month; the PT-141 + Oxytocin directions cap it at eight. Report any new darkening. More on the shared receptor is in PT-141 vs Melanotan II.

The approved label lists two:

There is no established interaction list for the compounded PT-141 + Oxytocin combination. That is why the intake asks for every medication you take, including anything for blood pressure or erectile function, and why a physician reviews it rather than a form.

The combination's side effects are dominated by its PT-141 component, so nausea, flushing, headache, the blood pressure rise and the pigmentation warning all apply. Each typical 0.10 mL dose delivers 0.2 mg PT-141 and 0.1 mg oxytocin. For the oxytocin component at small subcutaneous doses there are no systematic safety data, which is an honest gap rather than a reassurance. Oxytocin's primary peripheral action is contracting the uterus, one reason pregnancy is an absolute exclusion. Details are in what is PT-141 + Oxytocin and what is oxytocin.

Never take an extra dose to push through a side effect, and never take a second dose within 24 hours. If you have questions about your dose, message your care team rather than adjusting anything yourself.

Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

The phase 3 data, and almost all of the percentages on this page, come from premenopausal women. The men's programme was early-phase: two 2004 studies in the International Journal of Impotence Research reported erectile responses to intranasal and subcutaneous PT-141, including erections without visual sexual stimulation, the signature of a drug acting in the brain. Those studies measured response over hours and did not produce a side-effect table in our sources. The mechanism is the same in men and women, so the blood pressure, nausea and pigmentation warnings apply to everyone. An erection lasting more than four hours needs emergency care.

PT-141's side-effect profile is better characterised than that of almost any other peptide prescribed today, because the same active ingredient went through two phase 3 trials, a year-long extension and a pooled safety analysis of roughly 3,500 subjects. The limits: those data come mainly from premenopausal women using a fixed 1.75 mg autoinjector, up to eight times a month. There are no comparable data in men, in postmenopausal women, or for a compounded multi-dose vial. For the oxytocin in the combination vial, there are no systematic safety data at these doses. The full benefit and evidence picture is in PT-141 benefits, and the dosing detail in PT-141 dosage.

PT-141 cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested, and a side-effect profile only means something when the dose is known. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with your directions printed on the vial, with sterile syringes and alcohol prep pads.
5. Your physician stays reachable for questions, side effects and dose changes.

Pepti prescribes PT-141 in every state except Oklahoma, plus DC Step by step: how to get PT-141 prescribed online. The wider intimacy picture is in peptides for libido.